Med 润色咨询

Med

出版年份：暂无数据 年文章数：87 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1193755, encodeId=dc751193e55f0, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:37:11 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193227, encodeId=a370119322e8f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;再生医学;医学综合<br>经验分享：经验分享：Cell的子刊，定位于Cell, Chem, Joule这个级别，未来可期！！<br>接收领域很广，定位于转化医学，不象Cell太过生命科学（基础），也不象Lancet这一类过于临床，Med应该是二者之间，转化医学层面，虽然类似期刊竞争很激烈，但是大树下好乘凉，不要错过这个未来潜力股<br>下面都是收稿范围：<br>✚ Aging and health-span interventions – sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disorders<br>✚ Biomedical engineering – new device optimization and diagnostic tools<br>✚ Cancer – immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalities<br>✚ Cardiovascular and metabolic disease – heart disease; diabetes; obesity; NAFLD/NASH<br>✚ Genetics and cell-based therapies – medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantation<br>✚ Health economics and public policy – global challenges; health access; public health interventions; clinical practices<br>✚ Human microbiome – mechanistic studies of the human microbiome’s impact on disease<br>✚ Immunology – allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinology<br>✚ Infectious diseases – HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistance<br>✚ Neurology – Alzheimer’s disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinson’s and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapies<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Feb 14 09:55:21 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-15 梅斯助教

    #期刊推荐#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193755, encodeId=dc751193e55f0, content=<a href='/topic/show?id=b40310445682' target=_blank style='color:#2F92EE;'>#期刊推荐#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104456, encryptionId=b40310445682, topicName=期刊推荐)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=梅斯助教, createdTime=Tue Feb 15 21:37:11 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193227, encodeId=a370119322e8f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：干细胞;再生医学;医学综合<br>经验分享：经验分享：Cell的子刊，定位于Cell, Chem, Joule这个级别，未来可期！！<br>接收领域很广，定位于转化医学，不象Cell太过生命科学（基础），也不象Lancet这一类过于临床，Med应该是二者之间，转化医学层面，虽然类似期刊竞争很激烈，但是大树下好乘凉，不要错过这个未来潜力股<br>下面都是收稿范围：<br>✚ Aging and health-span interventions – sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disorders<br>✚ Biomedical engineering – new device optimization and diagnostic tools<br>✚ Cancer – immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalities<br>✚ Cardiovascular and metabolic disease – heart disease; diabetes; obesity; NAFLD/NASH<br>✚ Genetics and cell-based therapies – medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantation<br>✚ Health economics and public policy – global challenges; health access; public health interventions; clinical practices<br>✚ Human microbiome – mechanistic studies of the human microbiome’s impact on disease<br>✚ Immunology – allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinology<br>✚ Infectious diseases – HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistance<br>✚ Neurology – Alzheimer’s disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinson’s and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapies<br><br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Mon Feb 14 09:55:21 CST 2022, time=2022-02-14, status=1, ipAttribution=)]
    2022-02-14 医者仁者

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：干细胞;再生医学;医学综合
    经验分享：经验分享：Cell的子刊，定位于Cell, Chem, Joule这个级别，未来可期！！
    接收领域很广，定位于转化医学，不象Cell太过生命科学（基础），也不象Lancet这一类过于临床，Med应该是二者之间，转化医学层面，虽然类似期刊竞争很激烈，但是大树下好乘凉，不要错过这个未来潜力股
    下面都是收稿范围：
    ✚ Aging and health-span interventions – sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disorders
    ✚ Biomedical engineering – new device optimization and diagnostic tools
    ✚ Cancer – immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalities
    ✚ Cardiovascular and metabolic disease – heart disease; diabetes; obesity; NAFLD/NASH
    ✚ Genetics and cell-based therapies – medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantation
    ✚ Health economics and public policy – global challenges; health access; public health interventions; clinical practices
    ✚ Human microbiome – mechanistic studies of the human microbiome’s impact on disease
    ✚ Immunology – allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinology
    ✚ Infectious diseases – HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistance
    ✚ Neurology – Alzheimer’s disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinson’s and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapies

    0

共2条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分